AuntMinnie

MAY 31, 2024

PET imaging with nitrogen-13 (N-13) ammonia radiotracer can help predict major adverse cardiac events in patients with ischemic heart disease (IHD), according to a study published May 30 in Radiology: Cardiothoracic Imaging. Patients underwent the scans between January 2017 and January 2021.

Disease 110

Disease PET Scan Hospital Imaging 110

AuntMinnie

OCTOBER 2, 2024

tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image.

Digital Imaging and Communications in Medicine 143

Digital Imaging and Communications in Medicine X-ray MRI Hospital 143

AuntMinnie

JUNE 30, 2024

Welcome to the 2002 edition of the Minnies, AuntMinnie.com’ s annual event to recognize the best of radiology! Congratulations to the winners, and thanks to everyone who participated! Martha Koperwhats, Texas Children's Hospital 2. Enrico Perez, Columbia Presbyterian-Cornell University Hospitals BEST RADIOLOGIST TRAINING PROGRAM 1.

Radiology Technologist 105

Radiology Technologist PET Scan X-ray Education 105

Imaging Technology

MAY 31, 2023

CR and CNR demonstrated using clinical data with inserted lesions of known size, location, and contrast. Quantitation accuracy demonstrated using clinical data with inserted lesions of known size, location, and contrast (ground truth). Since there is no “typical” hospital and many variables exist, i.e. hospital size, case mix, etc.

Nuclear Medicine 98

Nuclear Medicine Healthcare Healthcare IT 98

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since the U.S. please insert video here.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since the U.S.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

JULY 1, 2024

In small studies, F-18 PSMA-1007 PET/CT has shown promise as a more accurate approach based on its ability to reveal prostate-specific membrane antigen (PSMA) on the surface of cancer cells. In this phase II clinical trial, the researchers sought to evaluate the approach further.

MRI 105

MRI PET Scan Nuclear Medicine Bone Scan 105